Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects
NCT ID: NCT06639555
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2022-06-24
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet-rich Fibrin and Autogenous Bone vs Enamel Matrix Derivative and Autogenous Bone in Intrabony Defects
NCT03510780
Guided Bone Regeneration Using Bovine-derived Xenograft in Combination With or Without Injectable Platelet-rich Fibrin
NCT04709523
Regenerative Combined Therapy With Enamel Matrix Derivative and Biphasic Calcium Phosphate Graft
NCT02828423
Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs
NCT02209311
Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane
NCT04286334
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRP alone
PRP( platelet rich plasma)
regenerative therapy with PRP for vertical bone defects
EMD Alone
EMD (Enamel Matrix Derivative)
regenerative therapy with EMD for vertical bone defects
GTR (barrier membrane)
Guided Tissue Regeneration (barrier membrane)
guided tissue regeneration with barrier membrane alone for vertical bone defects
GTR(barrier membrane and PRP)
Guided Tissue Regeneration(barrier membrane and PRP)
guided tissue regeneration with barrier membrane and PRP for vertical bone defects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRP( platelet rich plasma)
regenerative therapy with PRP for vertical bone defects
EMD (Enamel Matrix Derivative)
regenerative therapy with EMD for vertical bone defects
Guided Tissue Regeneration (barrier membrane)
guided tissue regeneration with barrier membrane alone for vertical bone defects
Guided Tissue Regeneration(barrier membrane and PRP)
guided tissue regeneration with barrier membrane and PRP for vertical bone defects
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
* age
* no systemic diseases
Exclusion Criteria
* horizontal bone loss
* untreated periodontium disease
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tsvetalina Gerova-Vatsova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tsvetalina Gerova-Vatsova
Assistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University - Varna
Varna, Varna, Bulgaria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
118/23.06.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.